FindTrial
Sign In

Clinical trial of transcutaneous electrical nerve stimulation in treating refractory overactive bladder

Transcutaneous electrical nerve stimulation and solifenacin versus solifenacin alone in the treatment of overactive bladder syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016280
Enrollment
Unknown
Registered
2018-05-24
Start date
2018-06-01
Completion date
Unknown
Last updated
2018-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

overactive bladder

Interventions

A:oral solifenacin
B:oral solifenacin and TENS

Sponsors

Chanjuan Zhang
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) female with age between 18 and 75 years; 2) without previous medical treatment; 3) had no evidence of urinary tract infection.

Exclusion criteria

Exclusion criteria: With any of the listed diseases (including but not limited to) pelvic tumor, lithiasis, genital prolapse, urinary tract obstruction, etc.

Design outcomes

Primary

MeasureTime frame
OAB symptom score;—

Secondary

MeasureTime frame
Urodynamic test;—

Countries

China

Contacts

Public ContactChanjuan Zhang
zcj710605@163.com+86 13853142629

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026